No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ATEX240719P35000
- 0.02
- -0.14-87.50%
15min DelayClose Jul 19 14:45 ET
0.05High0.02Low
0.05Open0.16Pre Close2 Volume126 Open Interest35.00Strike Price7.00Turnover653.78%IV12.11%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0208Delta0.0196Gamma1990.00Leverage Ratio-1.6787Theta0.0000Rho-41.38Eff Leverage0.0002Vega
Intraday
- 5D
- Daily
News
Express News | Anterix Announces Board of Directors Nominees
Institutional Investors Have a Lot Riding on Anterix Inc. (NASDAQ:ATEX) With 55% Ownership
Key Insights Institutions' substantial holdings in Anterix implies that they have significant influence over the company's share price 54% of the business is held by the top 5 shareholders Using d
Insiders Of Anterix Reap Rewards After Their Investment Jumps Another US$857k
Earnings Call Summary | Anterix(ATEX.US) Q4 2024 Earnings Conference
The following is a summary of the Anterix Inc. (ATEX) Q4 2024 Earnings Call Transcript:Financial Performance:FY 2024 ended with over $60 million in cash and no debt.Signed $64 million in new contracts
Anterix Inc. (ATEX) Q4 2024 Earnings Call Transcript
Anterix Inc. (ATEX) Q4 2024 Earnings Call Transcript
Craig-Hallum Initiates Anterix(ATEX.US) With Buy Rating
Craig-Hallum analyst Christian Schwab initiates coverage on $Anterix(ATEX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 61.1% and a total average return of 17.2%
Comments
Anterix's leaders are confident in Kuhn's experience and potential impact on the company. Kuhn applauds Anterix's dedication to the utility sector as a collective industry communication strategy.
Press Release: ELECTRIC UTILITY INDUSTRY LEADER TOM KUHN JOINS ANTERIX BOARD OF DIRECTORS AS VICE CHAIRMAN 1
$Anterix(ATEX.US$ ANTERIX ANNOUNCES AUTHORIZATION OF A NEW $250 MILLION SHARE REPURCHASE PROGRAM
2
1
Markets were relatively quiet with investors largely in wait-and-see mode ahead of next week's inflation data and Federal Reserve interest-rate decision. Major indexes posted modest gains and losses over the course of the week.
$Tesla(TSLA.US$ shares, which had surged all week long, extended their advance Friday after General Motors said the prior afternoon that it would produce electric vehicles with Tesla charge ...
$Tesla(TSLA.US$ shares, which had surged all week long, extended their advance Friday after General Motors said the prior afternoon that it would produce electric vehicles with Tesla charge ...
+2
26
3
Gainers:
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
18
1
Read more